Your browser doesn't support javascript.
loading
Role of Chemotherapy in Gastric Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type / 대한내과학회지
Korean Journal of Medicine ; : 706-711, 2012.
Article in Ko | WPRIM | ID: wpr-211755
Responsible library: WPRO
ABSTRACT
Gastric mucosa-associated lymphoid tissue (MALT) lymphoma comprises approximately 50% of primary gastric lymphoma. Currently, Helicobacter pyroli eradication is the mainstay in the management of localized gastric MALT lymphoma. However, other treatment strategies such as radiotherapy and chemotherapy should be required in certain circumstances which include H. pyroli-negative disease, H. pyroli-positive disease unresponsive to standard eradication, and advanced disease (stage III/IV). Here, we reviewed the role of chemotherapy in the management of patients with gastric MALT lymphoma based on recent clinical trials.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Stomach Neoplasms / Lymphoma, Non-Hodgkin / Helicobacter / Lymphoma, B-Cell, Marginal Zone / Lymphoid Tissue / Lymphoma Limits: Humans Language: Ko Journal: Korean Journal of Medicine Year: 2012 Type: Article
Full text: 1 Index: WPRIM Main subject: Stomach Neoplasms / Lymphoma, Non-Hodgkin / Helicobacter / Lymphoma, B-Cell, Marginal Zone / Lymphoid Tissue / Lymphoma Limits: Humans Language: Ko Journal: Korean Journal of Medicine Year: 2012 Type: Article